CLINICAL RESEARCH: HEART FAILURE
Selective Functional Exhaustion of Hematopoietic Progenitor Cells in the Bone Marrow of Patients With Postinfarction Heart Failure
Christine K. Kissel, MD1,
Ralf Lehmann, MD,
Birgit Assmus, MD,
Alexandra Aicher, MD,
Jörg Honold, MD,
Ulrich Fischer-Rasokat, MD,
Christopher Heeschen, MD,
Ioakim Spyridopoulos, MD,
Stefanie Dimmeler, PhD and
Andreas M. Zeiher, MD*
Department of Cardiology, Johann Wolfgang GoetheUniversity Frankfurt, Frankfurt, Germany.
Manuscript received February 14, 2006;
revised manuscript received January 11, 2007,
accepted January 22, 2007.
* Reprint requests and correspondence: Dr. Andreas M. Zeiher, Department of Cardiology, University of Frankfurt, Theodor Stern-Kai 7, 60590 Frankfurt, Germany. (Email: zeiher{at}em.uni-frankfurt.de).
Objectives: This study investigated whether reduced levels of circulating endothelial progenitors cells (EPCs) in chronic heart failure (CHF) are secondary to an exhaustion of hematopoietic stem cells (HSCs) in the bone marrow or to reduced mobilization.
Background: Circulating EPCs presumably originate from bone marrow-derived HSC. Persistent mobilization of EPCs was shown to be associated with favorable left ventricular infarct remodeling processes.
Methods: We assessed the number and functional capacity of EPCs in 17 healthy controls, 25 patients with ischemic cardiomyopathy (ICM), and 20 patients with dilated cardiomyopathy (DCM). To document an impairment of HSC function in the bone marrow, the colony-forming unit capacity of bone marrowderived mononuclear cells and the number of CD34+ HSCs were examined in 6 healthy volunteers, 94 ICM patients, and 25 DCM patients.
Results: The number of EPCs was reduced in CHF, irrespective of its etiology. In contrast, the migratory capacity was selectively impaired in EPCs of ICM patients (4.8 ± 4.0 migrated cells; DCM 9.7 ± 5.8; p = 0.02). On multivariate analysis, ICM, advanced New York Heart Association functional class, and CHF were independent predictors of functional EPC impairment. The number of bone marrow-derived CD34+ cells did not differ between the CHF populations. However, colony-forming units (CFUs) were selectively reduced in ICM patients (54.4 ± 24.6; DCM 68.1 ± 26.9; p < 0.02). Ischemic cardiomyopathy was the only independent predictor of impaired CFU capacity. Impaired CFU capacity was associated with reduced matrix metalloproteinase-9 activity in the bone marrow plasma.
Conclusions: Ischemic cardiomyopathy is associated with selective impairment of progenitor cell function in the bone marrow and in the peripheral blood, which may contribute to an unfavorable left ventricular (LV) remodeling process.
|
Abbreviations and Acronyms
| | BM-MNC = bone marrowderived mononuclear cell | | CAD = coronary artery disease | | CFU-GM = colony-forming unitgranulocyte-macrophage | | CHF = chronic heart failure | | DCM = dilated cardiomyopathy | | EPC = endothelial progenitor cell | | EPO = erythropoietin | | HSC = hematopoietic stem cell | | hsCRP = high-sensitivity C-reactive protein | | ICM = ischemic cardiomyopathy | | LV = left ventricular | | MI = myocardial infarction | | MMP = matrix metalloproteinase | | NT-proBNP = N-terminal pro-brain natriuretic peptide | | NYHA = New York Heart Association | | PlGF = placental growth factor | | TNF = tumor necrosis factor | | VEGF = vascular endothelial growth factor |
|
Related Article
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2007 49: A23-A24.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
X. Wang, J. Takagawa, V. C. Lam, D. J. Haddad, D. L. Tobler, P. Y. Mok, Y. Zhang, B. T. Clifford, K. Pinnamaneni, S. A. Saini, et al.
Donor Myocardial Infarction Impairs the Therapeutic Potential of Bone Marrow Cells by an Interleukin-1-Mediated Inflammatory Response
Science Translational Medicine,
September 14, 2011;
3(100):
100ra90 - 100ra90.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Thum, K. Schmitter, F. Fleissner, V. Wiebking, B. Dietrich, J. D. Widder, V. Jazbutyte, S. Hahner, G. Ertl, and J. Bauersachs
Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans
Eur. Heart J.,
May 2, 2011;
32(10):
1275 - 1286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Maltais, L. P. Perrault, and H. Q. Ly
The bone marrow-cardiac axis: role of endothelial progenitor cells in heart failure
Eur J Cardiothorac Surg,
March 1, 2011;
39(3):
368 - 374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Jie, K. van der Putten, M. W. T. Bergevoet, P. A. Doevendans, C. A. J. M. Gaillard, B. Braam, and M. C. Verhaar
Short- and long-term effects of erythropoietin treatment on endothelial progenitor cell levels in patients with cardiorenal syndrome
Heart,
January 1, 2011;
97(1):
60 - 65.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Dotsenko, Q. Xiao, Q. Xu, and M. Jahangiri
Bone Marrow Resident and Circulating Progenitor Cells in Patients Undergoing Cardiac Surgery
Ann. Thorac. Surg.,
December 1, 2010;
90(6):
1944 - 1951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Povsic, J. Zhou, S. D. Adams, M. P. Bolognesi, D. E. Attarian, and E. D. Peterson
Aging Is Not Associated With Bone Marrow-Resident Progenitor Cell Depletion
J Gerontol A Biol Sci Med Sci,
October 1, 2010;
65A(10):
1042 - 1050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Psaltis, A. Carbone, A. J. Nelson, D. H. Lau, T. Jantzen, J. Manavis, K. Williams, S. Itescu, P. Sanders, S. Gronthos, et al.
Reparative Effects of Allogeneic Mesenchymal Precursor Cells Delivered Transendocardially in Experimental Nonischemic Cardiomyopathy
J. Am. Coll. Cardiol. Intv.,
September 1, 2010;
3(9):
974 - 983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Van Craenenbroeck, P. J. Beckers, N. M. Possemiers, K. Wuyts, G. Frederix, V. Y. Hoymans, F. Wuyts, B. P. Paelinck, C. J. Vrints, and V. M. Conraads
Exercise acutely reverses dysfunction of circulating angiogenic cells in chronic heart failure
Eur. Heart J.,
August 1, 2010;
31(15):
1924 - 1934.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Westenbrink, A. A. Voors, R. A. de Boer, J. J. Schuringa, T. Klinkenberg, P. van der Harst, E. Vellenga, D. J. van Veldhuisen, and W. H. van Gilst
Bone marrow dysfunction in chronic heart failure patients
Eur J Heart Fail,
July 1, 2010;
12(7):
676 - 684.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Dimmeler
Regulation of Bone Marrow-Derived Vascular Progenitor Cell Mobilization and Maintenance
Arterioscler Thromb Vasc Biol,
June 1, 2010;
30(6):
1088 - 1093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Koyanagi, M. Iwasaki, S. Rupp, F. S. Tedesco, C. H. Yoon, J. N. Boeckel, J. Trauth, C. Schutz, K. Ohtani, R. Goetz, et al.
Sox2 Transduction Enhances Cardiovascular Repair Capacity of Blood-Derived Mesoangioblasts
Circ. Res.,
April 16, 2010;
106(7):
1290 - 1302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S.M. Wong, J. Huzen, P. van der Harst, R. A. de Boer, V. Codd, B. Daan Westenbrink, G. F.J.D. Benus, A. A. Voors, W. H. van Gilst, N. J. Samani, et al.
Anaemia is associated with shorter leucocyte telomere length in patients with chronic heart failure
Eur J Heart Fail,
April 1, 2010;
12(4):
348 - 353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-S. Li, M. Kubo, K. Ueda, M. Murakami, A. Mikamo, and K. Hamano
Impaired angiogenic potency of bone marrow cells from patients with advanced age, anemia, and renal failure
J. Thorac. Cardiovasc. Surg.,
February 1, 2010;
139(2):
459 - 465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Spyridopoulos, J. Hoffmann, A. Aicher, T. H. Brummendorf, H. W. Doerr, A. M. Zeiher, and S. Dimmeler
Accelerated Telomere Shortening in Leukocyte Subpopulations of Patients With Coronary Heart Disease: Role of Cytomegalovirus Seropositivity
Circulation,
October 6, 2009;
120(14):
1364 - 1372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Akar, S. Durdu, M. Arat, M. Kilickap, N. O. Kucuk, O. Arslan, I. Kuzu, and U. Ozyurda
Five-year follow-up after transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischaemic cardiomyopathy
Eur J Cardiothorac Surg,
October 1, 2009;
36(4):
633 - 643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Brunskill, C. J. Hyde, C. J. Doree, S. M. Watt, and E. Martin-Rendon
Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease
Eur J Heart Fail,
September 1, 2009;
11(9):
887 - 896.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Dotsenko and M. Jahangiri
Endogenous stem cells in patients undergoing coronary artery bypass graft surgery
Eur J Cardiothorac Surg,
September 1, 2009;
36(3):
563 - 571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Shabbir, D. Zisa, G. Suzuki, and T. Lee
Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen
Am J Physiol Heart Circ Physiol,
June 1, 2009;
296(6):
H1888 - H1897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kamota, T.-S. Li, N. Morikage, M. Murakami, M. Ohshima, M. Kubo, T. Kobayashi, A. Mikamo, Y. Ikeda, M. Matsuzaki, et al.
Ischemic Pre-Conditioning Enhances the Mobilization and Recruitment of Bone Marrow Stem Cells to Protect Against Ischemia/Reperfusion Injury in the Late Phase
J. Am. Coll. Cardiol.,
May 12, 2009;
53(19):
1814 - 1822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Leone, M. Valgimigli, M. B. Giannico, V. Zaccone, M. Perfetti, D. D'Amario, A. G. Rebuzzi, and F. Crea
From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells
Eur. Heart J.,
April 2, 2009;
30(8):
890 - 899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Schachinger, A. Aicher, N. Dobert, R. Rover, J. Diener, S. Fichtlscherer, B. Assmus, F. H. Seeger, C. Menzel, W. Brenner, et al.
Pilot Trial on Determinants of Progenitor Cell Recruitment to the Infarcted Human Myocardium
Circulation,
September 30, 2008;
118(14):
1425 - 1432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Dimmeler and A. Leri
Aging and Disease as Modifiers of Efficacy of Cell Therapy
Circ. Res.,
June 6, 2008;
102(11):
1319 - 1330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Povsic and P. J. Goldschmidt-Clermont
Review: Endothelial progenitor cells: markers of vascular reparative capacity
Therapeutic Advances in Cardiovascular Disease,
June 1, 2008;
2(3):
199 - 213.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Zampetaki, J. P. Kirton, and Q. Xu
Vascular repair by endothelial progenitor cells
Cardiovasc Res,
June 1, 2008;
78(3):
413 - 421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Spyridopoulos, Y. Erben, T. H. Brummendorf, J. Haendeler, K. Dietz, F. Seeger, C. K. Kissel, H. Martin, J. Hoffmann, B. Assmus, et al.
Telomere Gap Between Granulocytes and Lymphocytes Is a Determinant for Hematopoetic Progenitor Cell Impairment in Patients With Previous Myocardial Infarction
Arterioscler Thromb Vasc Biol,
May 1, 2008;
28(5):
968 - 974.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, P. Clopton, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, J. D. Knoke, W. Y.W. Lew, J. A.C. Lima, et al.
Highlights of the Year in JACC 2007
J. Am. Coll. Cardiol.,
January 29, 2008;
51(4):
490 - 512.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Spyridopoulos, C. K. Kissel, S. Dimmeler, and A. M. Zeiher
Reply
J. Am. Coll. Cardiol.,
November 6, 2007;
50(19):
1912 - 1913.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Oeseburg, B. D. Westenbrink, R. A. de Boer, W. H. van Gilst, D. J. van Veldhuisen, and P. van der Harst
Can Critically Short Telomeres Cause Functional Exhaustion of Progenitor Cells in Postinfarction Heart Failure?
J. Am. Coll. Cardiol.,
November 6, 2007;
50(19):
1911 - 1912.
[Full Text]
[PDF]
|
 |
|
|